Woodline Partners’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29M | Buy |
+732,813
| New | +$29M | 0.15% | 202 |
|
|
2025
Q1 | – | Sell |
-107,610
| Closed | -$3.76M | – | 962 |
|
|
2024
Q4 | $3.76M | Buy |
+107,610
| New | +$3.76M | 0.03% | 543 |
|
|
2023
Q4 | – | Sell |
-315,094
| Closed | -$14.3M | – | 562 |
|
|
2023
Q3 | $14.3M | Sell |
315,094
-726,838
| -70% | -$33M | 0.17% | 173 |
|
|
2023
Q2 | $42.8M | Buy |
+1,041,932
| New | +$42.8M | 0.51% | 49 |
|
|
2022
Q4 | – | Sell |
-406,483
| Closed | -$18M | – | 799 |
|
|
2022
Q3 | $18M | Buy |
406,483
+276,575
| +213% | +$12.2M | 0.25% | 117 |
|
|
2022
Q2 | $4.81M | Sell |
129,908
-62,743
| -33% | -$2.32M | 0.07% | 268 |
|
|
2022
Q1 | $7.14M | Sell |
192,651
-218,803
| -53% | -$8.1M | 0.12% | 212 |
|
|
2021
Q4 | $12.5M | Buy |
411,454
+5,993
| +1% | +$182K | 0.18% | 158 |
|
|
2021
Q3 | $13.6M | Sell |
405,461
-558,327
| -58% | -$18.7M | 0.22% | 124 |
|
|
2021
Q2 | $38.4M | Buy |
963,788
+487,897
| +103% | +$19.5M | 0.72% | 32 |
|
|
2021
Q1 | $21.4M | Buy |
475,891
+144,514
| +44% | +$6.5M | 0.47% | 66 |
|
|
2020
Q4 | $18.7M | Buy |
+331,377
| New | +$18.7M | 0.5% | 62 |
|